Systemic therapy of plaque-type psoriasis ameliorates endothelial cell function: results of a prospective longitudinal pilot trial (Q39803888)

14 September 2017

Systemic therapy of plaque-type psoriasis ameliorates endothelial cell function: results of a prospective longitudinal pilot trial (English)

1 reference

14 September 2017

0 references

1 reference

Sandra Boehncke

1

1 reference

14 September 2017

Stephan Fichtlscherer

2

1 reference

14 September 2017

Rebekka Salgo

3

1 reference

14 September 2017

Jurate Garbaraviciene

4

1 reference

14 September 2017

Heike Beschmann

5

1 reference

14 September 2017

Sandra Diehl

6

1 reference

14 September 2017

Katja Hardt

7

1 reference

14 September 2017

Diamant Thaçi

8

1 reference

14 September 2017

Wolf-Henning Boehncke

9

1 reference

14 September 2017

18 December 2010

1 reference

Archives of Dermatological Research

14 September 2017

1 reference

14 September 2017

303

1 reference

14 September 2017

6

1 reference

14 September 2017

381-388

1 reference

https://scigraph.springernature.com/pub.10.1007/s00403-010-1108-6

14 September 2017

0 references

cites work

A study examining inter- and intrarater reliability of three scales for measuring severity of psoriasis: Psoriasis Area and Severity Index, Physician's Global Assessment and Lattice System Physician's Global Assessment.

1 reference

https://api.crossref.org/works/10.1007%2FS00403-010-1108-6

Managing comorbid disease in patients with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-010-1108-6

Psoriasis patients show signs of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-010-1108-6

Serum leptin levels, skin leptin and leptin receptor expression in psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-010-1108-6

Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-010-1108-6

Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-010-1108-6

Current severe psoriasis and the rule of tens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-010-1108-6

The risk of mortality in patients with psoriasis: results from a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-010-1108-6

Chronic plaque psoriasis is associated with increased arterial stiffness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-010-1108-6

Inflammation, atherosclerosis, and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-010-1108-6

Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-010-1108-6

Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-010-1108-6

Endothelial dysfunction in insulin resistance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-010-1108-6

Insulin resistance and endothelial cell dysfunction: studies in mammalian models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-010-1108-6

National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-010-1108-6

The hormone resistin links obesity to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-010-1108-6

Psoriasis: a possible risk factor for development of coronary artery calcification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-010-1108-6

Activated, not resting, platelets increase leukocyte rolling in murine skin utilizing a distinct set of adhesion molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-010-1108-6

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-010-1108-6

Novel and conventional biomarkers for prediction of incident cardiovascular events in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-010-1108-6

German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-010-1108-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-010-1108-6

Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-010-1108-6

Treatment goals in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-010-1108-6

Adipokines, myokines and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-010-1108-6

Plasma resistin levels and risk of myocardial infarction and ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-010-1108-6

10.1007/S00403-010-1108-6

21 January 2018

Identifiers

DOI

1 reference

14 September 2017

1 reference